Oxford based Sensyne grows medical research dataset to 60 million patients

Sensyne Health plc, the ethical Clinical AI company, has reached a milestone of access to a combined clinical research, clinical trial and real world de-identified and anonymised dataset of over 60 million patients. This enlarged dataset results from both Sensyne’s investment in virtual clinical development company, Phesi Inc. in January and the progress made by Sensyne and Phesi in building their respective data platforms.

Read the source article at businessinnovationmag.co.uk
2021-08-03 14:25:55